本頁面由Tiger Trade Technology Pte. Ltd.提供服務

德納維製藥

10.87
+0.08000.74%
盤後10.870.00000.00%17:40 EST
成交量:114.46萬
成交額:1,245.95萬
市值:12.76億
市盈率:-30.24
高:10.98
開:10.80
低:10.80
收:10.79
52周最高:14.63
52周最低:9.20
股本:1.17億
流通股本:9,891.23萬
量比:0.79
換手率:1.16%
股息:- -
股息率:- -
每股收益(TTM):-0.3595
每股收益(LYR):0.2100
淨資產收益率:-7.14%
總資產收益率:1.20%
市淨率:2.39
市盈率(LYR):51.76

資料載入中...

2024/04/02

重要事件披露

Form 8-K - Current report
2024/03/12

重要事件披露

Form 8-K - Current report
2024/03/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/02/22

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/02/22

重要事件披露

Form 8-K - Current report
2024/02/14

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/01/18

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/01/08

重要事件披露

Form 8-K - Current report
2024/01/05

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/01/03

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/12/01

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/11/17

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/11/03

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/11/03

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/03

重要事件披露

Form 8-K - Current report
2023/11/01

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/10/24

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/10/24

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/10/11

關聯方擬減持公告

Form 144 - Report of proposed sale of securities